We’ve developed a proprietary 3D multi-omics platform to decode the function of the entire human genome to rapidly identify new, high-confidence, first-in-class therapeutic targets for common diseases, 10x faster than other methods. The platform is generating unparalleled genetic validation of disease-relevant targets, in the most relevant cell types, across the entire human genome to more than double the probability of success.
